(Q85647777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

main subject

cervix uterine cancer

1 reference

Priya Ranjan Debata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mario R Castellanos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jimmie E Fata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sarah Baggett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sritha Rajupet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Anita Szerszen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sultana Begum

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Anita Mata

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Vundavalli V Murty

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Lynne M Opitz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Probal Banerjee

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

9 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

145-153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Epidemiology of Genital Human Papillomavirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Pregnancy outcome after loop electrosurgical excision procedure: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Potential mechanisms for HPV vaccine-induced long-term protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Phase II trial of curcumin in patients with advanced pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Bioavailability of curcumin: problems and promises

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Curcumin suppresses human papillomavirus oncoproteins, restores p53, rb, and ptpn13 proteins and inhibits benzo[a]pyrene‐induced upregulation of HPV E7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Screening the p53 status of human cell lines using a yeast functional assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Comprehensive molecular cytogenetic characterization of cervical cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Coupling to a cancer cell-specific antibody potentiates tumoricidal properties of curcumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Curcumin blocks brain tumor formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

HDAC inhibition decreases the expression of EGFR in colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Molecular biology of human papillomavirus infection and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

Treatment of vulvar intraepithelial neoplasia with topical imiquimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.005

10.1016/J.YGYNO.2012.12.005

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23234806%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference